Clinical implications of the serum platelet-to-lymphocyte ratio in the modern radiation oncology era: research update and literature review
Abstract Radiation therapy (RT) continues to be the primary approach for treating cancer, and numerous cancer biomarkers associated with oncological outcomes have been investigated in the context of RT. The serum platelet-to-lymphocyte ratio (PLR) is one of the emerging landmark biomarker in the onc...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2024-08-01
|
| Seri Bilgileri: | Radiation Oncology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13014-024-02485-8 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|